Similar articles

• Can ischemic colitis be differentiated from C difficile colitis in biopsy specimens?

  Dignan CR, Greenson JK. Dignan CR, et al. Am J Surg Pathol. 1997 Jun;21(6):706-10. doi: 10.1097/00000478-199706000-00011. Am J Surg Pathol. 1997. PMID: 9199649
• Non-IBD colitides: clinically useful histopathological clues.

  Villanacci V, Manenti S, Antonelli E, Chiudinelli M, Giuliano V, Bassotti G. Villanacci V, et al. Rev Esp Enferm Dig. 2011 Jul;103(7):366-72. doi: 10.4321/s1130-01082011000700006. Rev Esp Enferm Dig. 2011. PMID: 21770683 Review. English, Spanish.
• Interobserver variability and feasibility of polymerase chain reaction-based assay in distinguishing ischemic colitis from Clostridium difficile colitis in endoscopic mucosal biopsies.

  Wiland HO 4th, Procop GW, Goldblum JR, Tuohy M, Rybicki L, Patil DT. Wiland HO 4th, et al. Am J Clin Pathol. 2013 Jun;139(6):730-5. doi: 10.1309/AJCPG8AYN9MUWJXV. Am J Clin Pathol. 2013. PMID: 23690114
• Toxic megacolon due to fulminant Clostridium Difficile colitis.

  Griniatsos J, Dimitriou N, Tyritzis S, Pappas P, Sougioultzis S, Stravodimos K. Griniatsos J, et al. Acta Gastroenterol Belg. 2011 Jun;74(2):359-60. Acta Gastroenterol Belg. 2011. PMID: 21861326 No abstract available.
• [Clostridium difficile as etiological agent of pseudomembranous colitis].

  Olczak A, Grabczewska E. Olczak A, et al. Przegl Epidemiol. 2012;66(1):59-65. Przegl Epidemiol. 2012. PMID: 22708300 Review. Polish. No abstract available.